Are There Any Toxicological Concerns with Peptidoglycan in Non-Bacterial Systems?
In the context of biotechnology and medicine, peptidoglycan is often considered for its potential adjuvant properties in vaccines. While it can enhance immune responses, there is a need to assess the toxicological risks associated with its use, such as the potential for excessive inflammatory responses. Therefore, understanding the balance between its beneficial and adverse effects is essential for its safe application in non-bacterial systems.
